StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $10.13 | $9.80 | -3.21% | 0.0M |
| 05-12 | $9.50 | $9.88 | +4.00% | 0.0M |
| 05-13 | $9.88 | $9.88 | +0.00% | 0.0M |
| 05-14 | $10.02 | $10.02 | +0.05% | 0.0M |
| 05-15 | $9.76 | $9.76 | +0.00% | 0.0M |
| Metric | Annual 2023 2023-12-31 | Q3 2023 2023-09-30 |
|---|---|---|
Revenue | $70.07K | $70.77K |
Operating Income | $-1.80M | $-811.17K |
Net Income | $-2.04M | $-939.83K |
EPS (Diluted) | $-0.33 | $-0.15 |
Total Assets | $3.56M | Not available |
Total Liabilities | $3.94M | Not available |
Cash & Equivalents | $66.53K | $474.56K |
Free Cash Flow OCF − CapEx | $-1.47M | $-576.56K |
Shares Outstanding | 6.25M | 6.25M |
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.
No sell-side coverage available for EXOZ.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Fundamentals not available for EXOZ.
No fundamental metrics available yet for this ticker — common for ETFs, foreign issuers without US listing depth, very recent IPOs, or thinly-traded OTC names. The Financials tab pulls from SEC EDGAR directly and may still have data.